0

baddrivers

Justices look for line to draw in drug preemption case 

  • by
    • March 20, 2013

WASHINGTON – Deciding where the preemptive effect of federal rules governing drug manufacturing ends and states’ ability to impose liability on drug makers begins has never been an easy task — not even for the justices of the U.S. Supreme Court.
On Tuesday, the justices wrangled once again over the » […]

Original post by http://lawyersusaonline.com/blog/2013/03/20/justices-look-for-line-to-draw-in-drug-preemption-case/

Report bad drivers!

Related posts:

  1. Justices to rule on preemption of drug design defect claims  The U.S. Supreme Court has agreed to decide whether federal law preempts state law design defect claims targeting generic pharmaceutical...
  2. Justices tackle puzzling law in medical battery case  WASHINGTON – Attempts to sort out the meaning of a confusing and oddly worded statute to determine whether a Navy...
  3. Justices to consider attorney fees in vaccine case  The U.S. Supreme Court has agreed to decide whether a party whose petition under the National Vaccine Injury Compensation Program...
  4. Justices consider costs of debt collection suits  WASHINGTON – In a case involving prevailing party costs and an apparent conflict between a federal statute and a rule...
  5. Jury awards $285K in Fosamax case  In the latest bellwether case to go to trial over the osteoporosis drug Fosamax, a New York federal jury has...

Leave a comment